Search

Phuong N. Huynh

Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )

Most Active Art Unit
1644
Art Unit(s)
1641, 1644
Total Applications
2195
Issued Applications
1131
Pending Applications
251
Abandoned Applications
828

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5397412 [patent_doc_number] => 20090317475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'COMBINATION ANTITUMOR THERAPIES' [patent_app_type] => utility [patent_app_number] => 12/160091 [patent_app_country] => US [patent_app_date] => 2007-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2487 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317475.pdf [firstpage_image] =>[orig_patent_app_number] => 12160091 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/160091
COMBINATION ANTITUMOR THERAPIES Jan 2, 2007 Abandoned
Array ( [id] => 204017 [patent_doc_number] => 07628990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/647878 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26919 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/628/07628990.pdf [firstpage_image] =>[orig_patent_app_number] => 11647878 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/647878
Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof Dec 28, 2006 Issued
Array ( [id] => 5409576 [patent_doc_number] => 20090123474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLTL ANTAGONIST FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/097384 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17427 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123474.pdf [firstpage_image] =>[orig_patent_app_number] => 12097384 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/097384
COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLTL ANTAGONIST FOR TREATING CANCER Dec 11, 2006 Abandoned
Array ( [id] => 5247799 [patent_doc_number] => 20070244033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A C-MYC PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/608706 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30858 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244033.pdf [firstpage_image] =>[orig_patent_app_number] => 11608706 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/608706
METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A C-MYC PROTEIN Dec 7, 2006 Abandoned
Array ( [id] => 5563662 [patent_doc_number] => 20090136514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Tetracyclines for Treating Ocular Diseases and Disorders' [patent_app_type] => utility [patent_app_number] => 12/086146 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9651 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136514.pdf [firstpage_image] =>[orig_patent_app_number] => 12086146 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/086146
Tetracyclines for Treating Ocular Diseases and Disorders Dec 6, 2006 Abandoned
Array ( [id] => 5119252 [patent_doc_number] => 20070140966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Multivalent immunoglobulin-based bioactive assemblies' [patent_app_type] => utility [patent_app_number] => 11/633729 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 50239 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20070140966.pdf [firstpage_image] =>[orig_patent_app_number] => 11633729 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/633729
Multivalent immunoglobulin-based bioactive assemblies Dec 4, 2006 Issued
Array ( [id] => 5062555 [patent_doc_number] => 20070224194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis' [patent_app_type] => utility [patent_app_number] => 11/566195 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22454 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224194.pdf [firstpage_image] =>[orig_patent_app_number] => 11566195 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/566195
Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis Nov 30, 2006 Abandoned
Array ( [id] => 5342366 [patent_doc_number] => 20090181016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME' [patent_app_type] => utility [patent_app_number] => 12/095493 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19891 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181016.pdf [firstpage_image] =>[orig_patent_app_number] => 12095493 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/095493
FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME Nov 29, 2006 Abandoned
Array ( [id] => 10031497 [patent_doc_number] => 09072797 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies' [patent_app_type] => utility [patent_app_number] => 12/097508 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 11 [patent_no_of_words] => 9103 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12097508 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/097508
Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies Nov 29, 2006 Issued
Array ( [id] => 5159379 [patent_doc_number] => 20070172423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Composition and method for modulating vasculogenesis for angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/605607 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 28136 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172423.pdf [firstpage_image] =>[orig_patent_app_number] => 11605607 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/605607
Composition and method for modulating vasculogenesis for angiogenesis Nov 28, 2006 Abandoned
Array ( [id] => 4792662 [patent_doc_number] => 20080293636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Protein Constructs Designed for Targeting and Lysis of Cells' [patent_app_type] => utility [patent_app_number] => 12/094877 [patent_app_country] => US [patent_app_date] => 2006-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8052 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293636.pdf [firstpage_image] =>[orig_patent_app_number] => 12094877 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/094877
Protein constructs designed for targeting and lysis of cells Nov 22, 2006 Issued
Array ( [id] => 5278580 [patent_doc_number] => 20090130712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Compositions and Methods of Producing Hybrid Antigen Binding Molecules and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/085155 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 25432 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130712.pdf [firstpage_image] =>[orig_patent_app_number] => 12085155 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/085155
Compositions and methods of producing hybrid antigen binding molecules and uses thereof Nov 20, 2006 Issued
Array ( [id] => 5252803 [patent_doc_number] => 20070134259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Methods and compositions for pharmacologially controlled targeted immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/602493 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6870 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134259.pdf [firstpage_image] =>[orig_patent_app_number] => 11602493 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/602493
Methods and compositions for pharmacologially controlled targeted immunotherapy Nov 20, 2006 Abandoned
Array ( [id] => 281487 [patent_doc_number] => 07553486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Anti-VEGF treatment for radiation-induced vasculopathy' [patent_app_type] => utility [patent_app_number] => 11/598302 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3324 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553486.pdf [firstpage_image] =>[orig_patent_app_number] => 11598302 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/598302
Anti-VEGF treatment for radiation-induced vasculopathy Nov 12, 2006 Issued
Array ( [id] => 4492146 [patent_doc_number] => 07955807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => 'Method of measuring PTX3 with high sensitivity' [patent_app_type] => utility [patent_app_number] => 12/092272 [patent_app_country] => US [patent_app_date] => 2006-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13327 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/955/07955807.pdf [firstpage_image] =>[orig_patent_app_number] => 12092272 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/092272
Method of measuring PTX3 with high sensitivity Nov 9, 2006 Issued
Array ( [id] => 4759378 [patent_doc_number] => 20080311604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy' [patent_app_type] => utility [patent_app_number] => 12/091899 [patent_app_country] => US [patent_app_date] => 2006-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6846 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311604.pdf [firstpage_image] =>[orig_patent_app_number] => 12091899 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/091899
Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy Oct 31, 2006 Abandoned
Array ( [id] => 5545973 [patent_doc_number] => 20090155850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Horse:Human Chimeric Antibodies' [patent_app_type] => utility [patent_app_number] => 12/090166 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16611 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155850.pdf [firstpage_image] =>[orig_patent_app_number] => 12090166 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/090166
Horse:Human Chimeric Antibodies Oct 26, 2006 Abandoned
Array ( [id] => 560511 [patent_doc_number] => 07470773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-30 [patent_title] => 'Immunoglobulin E detection in mammalian species' [patent_app_type] => utility [patent_app_number] => 11/585712 [patent_app_country] => US [patent_app_date] => 2006-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3304 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470773.pdf [firstpage_image] =>[orig_patent_app_number] => 11585712 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/585712
Immunoglobulin E detection in mammalian species Oct 23, 2006 Issued
Array ( [id] => 5119351 [patent_doc_number] => 20070141065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Anti-VEGF antibodies' [patent_app_type] => utility [patent_app_number] => 11/583994 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 53346 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141065.pdf [firstpage_image] =>[orig_patent_app_number] => 11583994 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/583994
Anti-VEGF antibodies Oct 18, 2006 Issued
Array ( [id] => 5022214 [patent_doc_number] => 20070148180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Peptide-immunoglobulin-conjugate' [patent_app_type] => utility [patent_app_number] => 11/583547 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13314 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148180.pdf [firstpage_image] =>[orig_patent_app_number] => 11583547 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/583547
Peptide-immunoglobulin-conjugate Oct 18, 2006 Abandoned
Menu